✦ LIBER ✦

Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients

✍ Scribed by Junko Yoshida; Alisa Kim; Kimberly A. Pratzer; Walter J. Stark

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of besifloxacin ophthalmic suspen

✍ Jai G. Parekh; T. Hunter Newsom; Steven Nielsen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Aqueous Penetration and Biological Activ

✍ Dianne H. Kim; Walter J. Stark; Terrence P. O’Brien; James D. Dick 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Efficacy and Safety of Besifloxacin Opht

✍ Marguerite B. McDonald; Eugene E. Protzko; Lynne S. Brunner; Timothy W. Morris; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 923 KB

Safety of prophylactic intracameral moxi

✍ Cesar Ramon G. Espiritu; Victor L. Caparas; Joanne G. Bolinao 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 248 KB

Safety and Tolerability of Besifloxacin

✍ Timothy L. Comstock; Michael R. Paterno; Jennifer A. Lynch; Heleen H. DeCory; Da 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Efficacy and Safety of Besifloxacin Opht

✍ Timothy L. Comstock; Michael R. Paterno; Jennifer A. Lynch; Heleen H. DeCory; Da 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB